Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaflex Retreatment for Peyronie's Disease
NCT03767452Phase 4Unknown
- Sponsor
- Manhattan Medical Research Practice, PLLC
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Manhattan Medical Research Practice, PLLC. Status: unknown.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT03767452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03767452.